Pharma & Biotech Daily is a short, AI-generated, human-supervised briefing on what’s important in pharma and biotech. Each weekday we condense key news on pipelines, deals, regulation and strategy into a quick audio update for people who build, run and invest in life sciences. Produced by OWITH.ai, a boutique AI & data studio. Sponsor the show: https://sponsor.owith.ai
…
continue reading
Pharma And BioTech News Podcasts
Burma | Chicago Scientist 🥼🧪🔬 Covering biotech, pharma, and healthcare companies shaping the world 🧬🏥🌎 Stream new episodes every THURSDAY! https://linktr.ee/maneadkhin #biotech #pharma #healthcare #podcast #petridishperspectives
…
continue reading
Pharmaceutical and biotech news in 5 minutes. Drug approvals, clinical trials, and healthcare innovation.
…
continue reading
Welcome to The Pharma Podcast - Insights from industry experts and business leaders about important and current topics in Canadian Pharma, Biotech and Medtech.
…
continue reading
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.
…
continue reading
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday. The host is Dylan Kissane.
…
continue reading
The Pharma Letter Podcast provides in-depth discussion and analysis focused on key trends, companies and events in the pharmaceutical and biotech industries. Our guests come from a broad array of sectors and business functions, from early stage research in biopharmaceuticals, to patient engagement and marketing, supply chain management and life sciences investing. Podcasts are typically 20-30 minutes in length and are released approximately once every two weeks.
…
continue reading
News and Analysis of the Biotech and Pharma Industry for Investors and Executives.
…
continue reading
A weekly audio digest of the most important news in drug development affecting the pharmaceutical and biotech industry
…
continue reading
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
…
continue reading
BioBiz Buzz offers exclusive insights into the biotech, pharma, and medtech industries through interviews with top executives and visionaries. Providing thought-provoking podcasts covering topics such as scientific advancements, emerging technologies, and market trends, to keep listeners informed about the latest developments in life sciences. Disclaimer https://biobizbuzz.com/disclaimer/
…
continue reading
This Life Science focused podcast brings together Xtalks editorial staff to share insights into the latest B2B industry news. Xtalks connects professionals in the life science, medical device, and food industries with useful content like webinars, job opening, articles and virtual meetings.
…
continue reading
Hosted by Melissa Lee and a roundtable of top traders, “Fast Money” breaks through the noise of the day, to deliver the actionable news that matters most to investors. Fast Money airs weeknights at 5p ET on CNBC. Visit http://fastmoney.cnbc.com for additional information.
…
continue reading
The impact of modern medicine on the human condition can’t be underestimated. From antibiotics to vaccines, medicine has changed the way our bodies work, answered deadly questions, and promised faster cures. But it’s not simple. Drug development is rife with tension. It costs a lot of money, and takes a long time. Most things fail. But when they succeed, they can make a tremendous difference in people’s lives. Where will the next breakthroughs come from? How will we pay for them? Who decides ...
…
continue reading
Welcome to the Ennovation Podcast, where we bring you the latest trends, insights and expertise in life sciences and regulatory affairs.
…
continue reading
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of pe ...
…
continue reading
Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage. Here we plug you into what’s new and exciting in the world of business.
…
continue reading
The Prospect Group is a leading global firm specializing in media, research, and consulting. We meet, and discuss the most relevant economic issues with, hundreds of the world’s leading business executives, political elites, and other influential personalities from a cross-section of industries and countries. Watch video interviews from and/or about Malaysia.
…
continue reading
This is Politics & Life Sciences (PLS) Radio which is an interplay of Life Sciences and Politics. I am your host Dean L. Fanelli, Ph.D. I am an Intellectual Property attorney in Washington, DC. My practice focuses on issues attendant to the Life Sciences industry. On PLS, we will explores cutting edge topics involving the Biotech and Pharma ecosystems and looks at political or governmental policy issues affecting the Biotech and Pharma industries. Each week, PLS will have amazing guests incl ...
…
continue reading
1
Pharma Innovations: Tariff Changes and Gene Therapies
6:54
6:54
Play later
Play later
Lists
Like
Liked
6:54
Send us a text Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we'll explore the latest advances and strategic moves shaping the industry, providing you with insights into how these developments might influence drug development and patient care.The pharmaceu…
…
continue reading
1
Bitcoin Leads Crypto Drop… And A 2026 AI Tech Outlook 12/1/25
43:32
43:32
Play later
Play later
Lists
Like
Liked
43:32
Bitcoin feeling the Thanksgiving hangover as the crypto space sells off. The tokens leading the losses, and how the Bitcoin treasury companies are feeling the pain as well. Plus Why the AI tech rally can keep rocking in the new year. Where one top tech analyst sees the most opportunity, as investors digest the latest AI power partnership. Fast Mone…
…
continue reading
1
EdgeMode scales AI infrastructure with Spain deal; CEO discusses unique model
7:59
7:59
Play later
Play later
Lists
Like
Liked
7:59
EdgeMode Inc (OTCID:EDGM) CEO Charlie Faulkner talked with Proactive's Stephen Gunnion about the company’s transformation into a major European AI infrastructure developer following a 1.5GW portfolio deal in Spain. Faulkner outlined how the five-site acquisition, made in partnership with BlackBerry AIF, enables Edgemode to build scalable, ready-to-…
…
continue reading
1
Kodal Minerals ships first lithium spodumene concentrate from Bougouni; CEO discusses progress
3:45
3:45
Play later
Play later
Lists
Like
Liked
3:45
Kodal Minerals PLC (AIM:KOD) CEO Bernard Aylward talked with Proactive's Stephen Gunnion about the company’s successful first shipment of lithium concentrate from its Bougouni Project in Mali, marking a significant milestone for the company.Aylward confirmed that the shipment was completed faster than expected, noting the efficient transport and po…
…
continue reading
1
Oakmount & Partners MD Glenn King on £500m social housing and care home bond strategy
6:14
6:14
Play later
Play later
Lists
Like
Liked
6:14
Oakmount & Partners Ltd managing director Glenn King spoke with Proactive’s Stephen Gunnion to discuss the company’s forthcoming £500 million listed bond, a major initiative designed to help meet the UK’s rapidly growing need for social housing and care home infrastructure. King explained that the bond was originally structured as a US$350 million …
…
continue reading
1
Connecting Excellence CEO on planned £1.5m Aquis IPO, Bitcoin treasury strategy and unique model
10:21
10:21
Play later
Play later
Lists
Like
Liked
10:21
Connecting Excellence Group Plc (XCE) CEO Scott Ellam talked with Proactive's Stephen Gunnion about the company's planned IPO on the Aquis Growth Market and its unique strategy combining executive recruitment with a Bitcoin treasury model.Ellam explained that XCE – Connecting Excellence Group – is the holding company for Spencer Riley, an internati…
…
continue reading
1
Andrew Thake: key trends at Resourcing Tomorrow 2025
5:44
5:44
Play later
Play later
Lists
Like
Liked
5:44
Resourcing Tomorrow divisional director Andrew Thake talked with Proactive's Stephen Gunnion about final preparations for the upcoming Resourcing Tomorrow 2025 conference.The event will welcome over 2,100 C-suite attendees from more than 90 countries. Thake said the conference has expanded in recent years to include the full mining value chain, not…
…
continue reading
1
ImmuPharma CEO confident on P140 partnership as strong pharma interest extends timeline into 2026
8:42
8:42
Play later
Play later
Lists
Like
Liked
8:42
ImmuPharma PLC (AIM:IMM) CEO Tim McCarthy talked with Proactive's Stephen Gunnion about the company's ongoing discussions to secure a partnership for its lead asset, P140. McCarthy addressed investor concerns following a recent update that indicated the timing of a potential deal may now move into 2026.He explained that while the company had initia…
…
continue reading
1
Buccaneer Energy adds acreage at Fouke; CEO details next steps
9:10
9:10
Play later
Play later
Lists
Like
Liked
9:10
Buccaneer Energy Plc (AIM:BUCE) CEO Paul Welch talked with Proactive's Stephen Gunnion about the company’s strategic progress in East Texas, focusing on its recent acreage acquisition and plans for the Allar #1, Turner #1, and Fouke #4 wells.Welch highlighted that the newly acquired lease provides operational flexibility, allowing Buccaneer to side…
…
continue reading
1
IP Group's Parkwalk Advisors sees scale-up gains from budget reforms
6:55
6:55
Play later
Play later
Lists
Like
Liked
6:55
Susie Harris, director of business development at Parkwalk Advisors, the fund management business of IP Group PLC (LSE:IPO), talked with Proactive's Stephen Gunnion about how UK government policy changes are set to improve the funding landscape for deep tech companies and university spinouts.Harris welcomed the decision, announced in Chancellor Rac…
…
continue reading
1
ReElement and SAGINT partner on blockchain tokenization to strengthen critical mineral traceability
3:50
3:50
Play later
Play later
Lists
Like
Liked
3:50
American Resources Corp CEO Mark Jensen joined Steve Darling to announce that the company’s subsidiary, ReElement Technologies, has entered into a Tokenization Services Agreement with SAGINT Inc., a provider of digital asset infrastructure focused on supply chain traceability and market price transparency. As part of the strategic partnership, Amer…
…
continue reading
1
Medicus Pharma applies for FDA priority voucher to accelerate SkinJect’s non-invasive BCC therapy
6:24
6:24
Play later
Play later
Lists
Like
Liked
6:24
Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive to announce that the company has formally submitted an FDA Commissioner’s National Priority Voucher (CNPV) application on behalf of its partner SkinJect, seeking expedited regulatory review for the Doxorubicin Microneedle Array (D-MNA) a novel, non-invasive treatment for basal c…
…
continue reading
1
November 2025: Biotech & Pharma NEWS Roundup
10:40
10:40
Play later
Play later
Lists
Like
Liked
10:40
Send us a text Welcome to your essential overview of the global biotech and pharmaceutical landscape for November 2025! This month was dominated by a surge in M&A activity, with high-profile bidding wars! 🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes! https://linktr.ee/maneadkhin #PetriDishPerspectives #BiotechNews #Pha…
…
continue reading
1
Advocacy, access and the future of cancer care take center stage in new Health Matters episode (Sponsored)
23:42
23:42
Play later
Play later
Lists
Like
Liked
23:42
GCI Health, Fersen and Fierce Pharma, hosts Ryan Kurzman and Wendy Lund explore the fast-shifting landscape of cancer care with Pam Traxel of the American Cancer Society Cancer Action Network. Traxel outlines the growing complexity facing patients—from navigating an expanding range of treatment options to managing rising costs—and explains why acce…
…
continue reading
1
Biokeiretsu: Transforming Biotech Through Collaboration
4:35
4:35
Play later
Play later
Lists
Like
Liked
4:35
Send us a text Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world.Today, we're diving into a fascinating exploration of how the biotechnology industry might evolve by adopting a model inspired by Japan's keiretsu system. This concept, known as "biokeiretsu," is being p…
…
continue reading
1
Curing cancer: Daiichi Sankyo's ambitious ADC approach
39:42
39:42
Play later
Play later
Lists
Like
Liked
39:42
Daiichi Sankyo has been pioneering ADCs since 2010, with a pipeline targeting over 30 indications and potentially reaching 400,000 patients. In today’s episode I’m joined by Dr. Markus Kosch, Head of the EU Oncology Business Division at Daiichi Sankyo. A physician by training with a deep academic background in oncology, Markus has spent over two de…
…
continue reading
1
Alzheimer's Breakthrough and Gene Therapy Milestones
4:35
4:35
Play later
Play later
Lists
Like
Liked
4:35
Send us a text Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today we dive into some of the most significant and exciting advancements shaping the industry.Let's start with a breakthrough coming out of recent clinical trials. A novel approach to treating Alzheime…
…
continue reading
1
Standard Uranium wins key permits, launching first drill program at Corvo in more than 40 years
5:23
5:23
Play later
Play later
Lists
Like
Liked
5:23
Standard Uranium Vice President of Exploration Sean Hillacre joined Steve Darling from Proactive to share that the company has received exploration permits for its Corvo Uranium Project, which is currently under a three-year earn-in option agreement with Aventis Energy. The approval clears the way for an ambitious field program that will include hi…
…
continue reading
Send us a text Unlock the future of immunotherapy. For decades, traditional antibody drugs were limited to tagging a single target. Now, meet the Bispecific Antibody (BsAb): a revolutionary molecule engineered to simultaneously grab two different targets, acting as a molecular "handcuff" to drag your immune system's most powerful killer, the T cell…
…
continue reading
1
CNBC Special Report: How Soaring U.S. Drug Prices Fueled What Feds Call An Illegal Import Of Medications 11/27/25
31:20
31:20
Play later
Play later
Lists
Like
Liked
31:20
Around the country, a pervasive question being asked: How can I afford my prescription drugs? The high cost of those medications, particularly very expensive drugs to treat serious diseases like multiple sclerosis and cystic fibrosis, have fueled a nationwide business in which insurance programs are using companies called “alternative funding progr…
…
continue reading
1
Transformative Regulatory Shifts and Drug Approvals
10:27
10:27
Play later
Play later
Lists
Like
Liked
10:27
Send us a text Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve deep into a series of transformative events that underscore the dynamic nature of our industry, where scientific innovation meets regulatory evolution and market adaptation.We begin with…
…
continue reading
Listen to our traders take you behind the money...how to play the volatility...pops and drops and the movers you missed. Fast Money Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.By CNBC
…
continue reading
1
Starpharma highlights major Oncology partnerships and 2026 clinical milestones
5:08
5:08
Play later
Play later
Lists
Like
Liked
5:08
Starpharma CEO Cheryl Maley joined Steve Darling from Proactive to discuss the company’s recent momentum in oncology development and strategic partnerships, underscoring growing commercial and clinical interest in its proprietary dendrimer-based drug delivery platform.Maley explained that Starpharma’s technology enables more efficient and targeted …
…
continue reading
1
MustGrow Biologics posts $0.8M in Q3 revenue as NexusBioAg drives margin growth
3:08
3:08
Play later
Play later
Lists
Like
Liked
3:08
MustGrow Biologics Corp Chief Executive Officer Corey Giasson joined Steve Darling from Proactive to discuss the company’s financial results for the three months ended September 30, 2025, highlighting a meaningful step forward in revenue generation and margin performance. During the quarter, MustGrow reported revenue of $0.8 million, marking a sign…
…
continue reading
1
Bitcoin's decline presents Black Friday buying opportunity, says Bitwise AM European head
6:31
6:31
Play later
Play later
Lists
Like
Liked
6:31
Bitwise Asset Management European head Bradley Duke talked with Proactive's Stephen Gunnion about the recent decline in Bitcoin's price and what it could mean for investors.Duke noted that while some view the fall from over $110,000 to $87,000 in November as a "disaster," others see it as a chance to accumulate at discounted levels. “It really is a…
…
continue reading
1
Amerant’s RNTA ETF targets yield in LatAm corporate bonds with active strategy
9:03
9:03
Play later
Play later
Lists
Like
Liked
9:03
Amerant Investments chief investment officer Baylor Lancaster-Samuel talked with Proactive's Stephen Gunnion about the launch and strategy behind the Amerant Latin American Debt UCITS ETF (RNTA).Lancaster-Samuel explained that RNTA was created to meet the needs of Latin American clients who want exposure to local corporates without the difficulties…
…
continue reading
1
Valereum secures $200m royalty and streaming deal with QGP; eyes Nasdaq listing
6:23
6:23
Play later
Play later
Lists
Like
Liked
6:23
Valereum PLC (AQSE:VLRM) CEO Gary Cottle talked with Proactive's Stephen Gunnion about the company’s newly announced $200 million royalty and streaming financing agreement with Quorum Global Photonics (QGP), a fund based in the Cayman Islands specialising in tokenisation and resource-based assets.Cottle explained that the deal involves a token swap…
…
continue reading
1
The Evolving Landscape of Respiratory and Immunology Drug Development with AstraZeneca’s Dr. Andrew Menzies-Gow
38:33
38:33
Play later
Play later
Lists
Like
Liked
38:33
In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Andrew Menzies-Gow, MBBS, PhD, Vice President Respiratory & Immunology, Global Biopharmaceuticals Medical, AstraZeneca, about innovations in respiratory and immunology drug development. Dr. Menzies-Gow is an expert in …
…
continue reading
1
Gene Therapy Breakthroughs and Regulatory Shifts
11:48
11:48
Play later
Play later
Lists
Like
Liked
11:48
Send us a text Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a landscape rich with scientific innovation, regulatory scrutiny, and strategic business decisions shaping the future of healthcare.Let's begin with Novartis, which has achieved…
…
continue reading
1
New Era Energy & Digital expands Texas AI campus to 438 acres through major land acquisition
9:29
9:29
Play later
Play later
Lists
Like
Liked
9:29
New Era Energy & Digital CEO Will Gray joined Steve Darling from Proactive to announce a major expansion milestone for the company’s flagship digital infrastructure development. Texas Critical Data Centers (TCDC)—the company’s 50/50 joint venture with Sharon AI, Inc.—has finalized a definitive purchase and sale agreement to acquire an additional 20…
…
continue reading
1
Power Metallic mines advances 100,000-metre drill program and targets January NYSE listing
4:29
4:29
Play later
Play later
Lists
Like
Liked
4:29
Power Metallic Mines CEO Terry Lynch joined Steve Darling from Proactive to provide an update on the company’s ongoing drilling activities and its planned listing on the New York Stock Exchange. Lynch noted that although the listing process experienced a brief delay due to the U.S. government shutdown, the company now expects to debut in New York i…
…
continue reading
Listen to our traders take you behind the money...how to play the volatility...pops and drops and the movers you missed. Fast Money Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.By CNBC
…
continue reading
1
Aftermath Silver completes Berenguela acquisition and secures early-payment benefits ahead of PFS
3:20
3:20
Play later
Play later
Lists
Like
Liked
3:20
Aftermath Silver CEO Ralph Rushton joined Steve Darling from Proactive to confirm that the company has completed the final payment required to secure full ownership of the Berenguela silver-copper-manganese project—nearly two years ahead of the original November 2026 deadline.Rushton explained that this early payment brought meaningful benefits. EM…
…
continue reading
1
Tooru PLC CEO: health and wellness brands driving growth
5:06
5:06
Play later
Play later
Lists
Like
Liked
5:06
Tooru PLC (LSE:RGO) CEO Scott Livingston talked with Proactive's Stephen Gunnion about the company's strategy for growth through its portfolio of health and wellness consumer brands.Livingston began by outlining the core brands under Tooru, including Juvela, a gluten-free range sold via prescription; OAF, its mass-market gluten-free line launched i…
…
continue reading
1
Rainbow Rare Earths de-risks Phalaborwa project with solvent extraction solution
9:14
9:14
Play later
Play later
Lists
Like
Liked
9:14
Rainbow Rare Earths Ltd (LSE:RBW, OTC:RBWRF) CEO George Bennett talked with Proactive's Stephen Gunnion about a major milestone in the company's development of the Phalaborwa rare earths project in South Africa.Bennett outlined how Rainbow’s decision to switch from ion chromatography to solvent extraction (SX) as the separation method for rare eart…
…
continue reading
1
Caledonia Mining greenlights Bilboes Project after robust feasibility results
8:08
8:08
Play later
Play later
Lists
Like
Liked
8:08
Caledonia mining CEO Mark Learmonth joined Steve Darling from Proactive to discuss the company’s decision to formally proceed with the development of the Bilboes gold project in Zimbabwe, following the completion of a comprehensive feasibility study. The long-awaited study confirmed the project’s compelling economics and positioned Bilboes as one o…
…
continue reading
1
Cordiant Digital Infrastructure reports £1bn NAV milestone; eyes value upside in 2026
8:41
8:41
Play later
Play later
Lists
Like
Liked
8:41
Cordiant Digital Infrastructure Management chairman Steven Marshall and Cordiant Digital Infrastructure Ltd (LSE:CORD) CFO Andrew Ewe talked with Proactive's Stephen Gunnion about the company’s continued financial performance and strategic progress, with net asset value (NAV) surpassing £1 billion.Marshall said the NAV growth reflects the strong de…
…
continue reading
1
Transformative Advances in Cancer Therapy and Regulatory Challenges
5:27
5:27
Play later
Play later
Lists
Like
Liked
5:27
Send us a text Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of impactful events and breakthroughs that are shaping patient care and drug development.The U.S. Food and Drug Administration recently granted early approval for a com…
…
continue reading
1
Tonix Pharmaceuticals launches TONMYA, a first-in-class non-opioid Fibromyalgia therapy
5:17
5:17
Play later
Play later
Lists
Like
Liked
5:17
Tonix Pharmaceuticals Holdings CEO Dr. Seth Lederman joined Steve Darling from Proactive to announce a major milestone for the company and for patients: TONMYA is now commercially available by prescription at pharmacies across the United States. TONMYA is a first-in-class, non-opioid analgesic designed specifically for adults with fibromyalgia and …
…
continue reading
Listen to our traders take you behind the money...how to play the volatility...pops and drops and the movers you missed. Fast Money Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.By CNBC
…
continue reading
1
Trust Stamp unveils patent-protected framework embedding biometric provenance in Stablecoins
4:06
4:06
Play later
Play later
Lists
Like
Liked
4:06
Trust Stamp EVP John Bridge joined Steve Darling from Proactive to outline the company’s newly announced patent-protected framework for embedding links to a biometrically validated, cryptographic chain of provenance directly into stablecoins. The update comes as global regulators intensify scrutiny on the misuse of stablecoins for illicit finance. …
…
continue reading
1
AtaiBeckley advances BPL-003 toward Phase 3 After Strong Phase 2 Data topline data i
5:15
5:15
Play later
Play later
Lists
Like
Liked
5:15
AtaiBeckley NV CEO Dr Srinivas Rao joined Steve Darling from Proactive to discuss the company’s official launch following the completion of the merger between Atai Life Sciences and Beckley Psytech, forming a new clinical-stage biopharmaceutical company focused on developing transformative treatments for mental health disorders.Rao said the combine…
…
continue reading
1
Northstar Gold strikes major innovation partnership to advance surgical mining at Cam Copper Project
4:48
4:48
Play later
Play later
Lists
Like
Liked
4:48
Northstar Gold Corp CEO Brian Fowler Joined Steve Darling from Proactive to reveal that the company has signed a Master Project Agreement with DIGITAL – Canada’s Global Innovation Cluster for digital technologies – alongside Novamera Inc. and Micon International Limited. The collaboration forms part of a broader initiative aimed at supporting data-…
…
continue reading
1
First Phosphate raises $3.5M, total funding reaches $43.6M Since 2022
2:16
2:16
Play later
Play later
Lists
Like
Liked
2:16
First Phosphate Corp. CEO John Passalacqua joined Steve Darling from Proactive to share that the company the company has closed another tranche of its non-brokered private placement, raising $3.5 million. This brings the total raised since June 2022 to roughly $43.6 million across 10 management-led financings.Passalacqua said the proceeds support F…
…
continue reading
1
Stuhini Exploration discovers promising new copper-gold porphyry target at Ruby Creek project
5:57
5:57
Play later
Play later
Lists
Like
Liked
5:57
Stuhini Exploration CEO Meredith Eades joined Steve Darling from Proactive to announce a significant new development at the company’s 100%-owned Ruby Creek Project near Atlin, British Columbia. Fieldwork from the 2025 exploration season has led to the identification of a potential new copper-gold porphyry system, marking a major addition to the pro…
…
continue reading
1
EnergyPathways CEO on major MESH expansion and catalysts ahead for investors
4:28
4:28
Play later
Play later
Lists
Like
Liked
4:28
EnergyPathways PLC (AIM:EPP) CEO Ben Clube talked with Proactive's Stephen Gunnion about the company’s recent developments on the MESH project, a major initiative designated as a project of national significance in the UK. This designation enables the project to progress under a streamlined development consent order process, helping to reduce appro…
…
continue reading
1
Western Star Resources CEO on 2026 drill plans; strategic tungsten positioning
5:43
5:43
Play later
Play later
Lists
Like
Liked
5:43
Western Star Resources Inc. (CSE:WSR, OTCQB:WSRIF) CEO Blake Morgan talked with Proactive's Stephen Gunnion about the company’s focus on advancing its exploration-stage projects as it prepares for a busy 2026 drill season.Morgan outlined the company’s two main assets: the flagship Western Star CRD (carbonate replacement deposit) project in British …
…
continue reading
1
Royalty Financing: Reshaping Biotech Funding in 2025
6:32
6:32
Play later
Play later
Lists
Like
Liked
6:32
Send us a text Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we dive into a series of significant stories shaping the future of healthcare, from innovative financing strategies to groundbreaking scientific advancements.The biotech industry in 2025 has expe…
…
continue reading
1
Stocks Bounce After Sell-Off… And Opportunity In The Credit Market 11/21/25
43:42
43:42
Play later
Play later
Lists
Like
Liked
43:42
Stocks closing out the week with a big leg higher, as equities rebound after an Nvidia led sell-off on Thursday. The sectors gaining ground, and if the volatility will continue into a shortened holiday week. Plus Rounding up all the retail data and results that came in this week, the huge move in airlines, restaurants, and housing stocks, and where…
…
continue reading
1
Silver Range Resources adds 2 new gold projects in Nevada and Utah, expanding U.S. exploration
5:45
5:45
Play later
Play later
Lists
Like
Liked
5:45
Silver Range Resources CEO Mike Power joined Steve Darling to announce that the company has significantly expanded its U.S. project portfolio by staking two new early-stage gold exploration properties the Quinn Property in Nevada and the Drum Property in Utah. The additions strengthen Silver Range’s strategy of identifying high-grade, drill-ready t…
…
continue reading
